AU3156493A — A pen-shaped syringe
Assigned to Novo Nordisk AS · Expires 1993-06-28 · 33y expired
What this patent protects
PCT No. PCT/DK92/00359 Sec. 371 Date May 20, 1994 Sec. 102(e) Date May 20, 1994 PCT Filed Nov. 30, 1992 PCT Pub. No. WO93/10839 PCT Pub. Date Jun. 10, 1993A pen-shaped syringe comprises a first part containing a dose setting and driving mechanism from which a piston rod is advanc…
USPTO Abstract
PCT No. PCT/DK92/00359 Sec. 371 Date May 20, 1994 Sec. 102(e) Date May 20, 1994 PCT Filed Nov. 30, 1992 PCT Pub. No. WO93/10839 PCT Pub. Date Jun. 10, 1993A pen-shaped syringe comprises a first part containing a dose setting and driving mechanism from which a piston rod is advanced by a carrier to actuate a piston of a reservoir in a second part. The first and second parts are coupled together by a bayonet coupling, wherein the bayonet coupling element of the second part has members for rotating a piston rod guide mounted on the bayonet coupling element of the first part. The piston rod determines the rotational position of the piston rod which rotational position again determines the engagement between the carrier and the piston rod.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.